Trial Profile
A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Testing CCX282-B in the Treatment of Celiac Disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Aug 2023
Price :
$35
*
At a glance
- Drugs Vercirnon (Primary)
- Indications Coeliac disease
- Focus Therapeutic Use
- Sponsors ChemoCentryx
- 25 Sep 2014 New trial record